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Impaired skeletal muscle function has been reported in patients with chronic obstructive
disease (COPD), but such impairment is not homogenous and its distribution between the
upper and the lower limbs is still unclear. The present study was designed to assess and
compare upper and lower limb capacities in patients with moderate to severe COPD during
incremental and constant-load exercises. Thirteen COPD patients of similar age with
moderate to severe air flow limitation (FEV1: 35%75% predicted) and 19 healthy subjects
were studied. Four sessions were organized: two incremental and two constant-load
cycling exercises with arm or leg in randomized order. As observed in a previous study
involving incremental and constant tests, power, V˙O2, RER, V˙E, and HR were all
significantly lower in the upper and lower limbs of patients with COPD than in healthy
controls. In the healthy population, aerobic capacity and mechanical efficiency (ME) were
lower in the course of arm exercises than in leg exercises. For the same relative workload,
dyspnea and blood lactate production were higher during arm exercise. In contrast, no
significant difference was observed between arm and leg capacities for any of these
parameters in COPD patients.Elsevier Ltd. All rights reserved.
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; PaO2, arterial oxygen pressure; PMA, maximal aerobic power; REE, resting energy expenditure; RER,
al volume; SaO2, oxygen saturation; TLC, total lung capacity; VAS, visual analogue scale; VC, vital
nute ventilation; V˙O2, O2 consumption; VT, tidal volume.
flicts of interest exist.
4 09 92 67; fax: +33 4 94 09 92 51.
wanadoo.fr (O. Castagna), alainboussuges@libertysurf.fr (A. Boussuges), Vallier@univ-toulon.fr
r.fr (C. Prefaut), Brisswalter@univ-toulon.fr (J. Brisswalter).
ARTICLE IN PRESS
O. Castagna et al.548Conclusion: Although aerobic capacity is impaired in COPD patients, arm aerobic capacity
is relatively preserved. Given the lack of significant difference between arm and leg
capacities in COPD, we hypothesize that upper limb muscles are less compromised than
lower limb muscles in this patient population.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive disease (COPD) is one of the leading
causes of both mortality and morbidity in developed
countries.1–4 It is now firmly established that this disease
is associated with impaired skeletal muscle function.5
Muscular deconditioning and genuine myopathy are the
two main etiologies underlying this phenomenon.6–8
A muscle’s oxidative and contractile capacities are
enhanced by regular use which is the reason why patients
with COPD are given pulmonary rehabilitation.5 However, in
such patients, some muscles are solicited even in the
absence of any special reeducation program.
This is true of the diaphragm in which impaired function is
partially reversed by the increased breathing effort even
without reeducation.9,10 Previous study reported that the
functioning of the diaphragms of the patients with stable
COPD was as good as in normal subjects at the same lung
volume.11 There is accumulating evidence that the dia-
phragm and other respiratory muscles are able to express
adaptive changes in response to the chronic mechanical load
imposed by the disease. This adaptation is accompanied by
increased endurance and remodeling of the diaphragmatic
muscle (increase in the number of mitochondria and changes
in the types of muscle fibers produced).12 We believe that
the same applies to the muscles of the upper arm for three
reasons: (i) in COPD, muscle strength and the muscle fiber
profile of the upper extremities are better preserved than in
the lower limbs13–15; (ii) quantification of physical activities
in daily life in COPD reported that these patients reduce use
of the lower limbs while use of the upper limbs remains
relatively unchanged; and (iii) certain muscles of the
scapular belt (the greater and smaller pectoral, greater
rectus and anterior serratus muscles) mobilize the shoulder
and also act as accessory respiratory muscles which are
constantly solicited because of respiratory resistance (which
is greater than in the healthy subject).16
We therefore hypothesize that, in patients with COPD,
the aerobic capacity of upper limb muscles is better
preserved than in the lower limb. To test this hypothesis,
we intended to compare metabolic and respiratory adapta-
tion in COPD during arm and leg pedaling exercises.
Furthermore, we will focus on mechanical efficiency (ME)
which reflects the conversion of chemical energy into
mechanical energy.17,18Methods
Subjects
Thirty five male subjects (mean age7SD, 6476) divided into
two groups were included in the study. Nineteen patientsfulfilled the criteria of COPD according to the American
Thoracic Society guidelines.19 Among this group, 17 patients
suffered from moderate IIb and two suffered from severe III
COPD severity according to GOLD classification.20 All
patients were clinically stable with absence of respiratory
exacerbation in the two months prior to the study.
In the second group, 16 healthy men were recruited. The
10 control subjects were in good health with no history of
lung disease, and with spirometry and lung volumes in the
normal range. None of the control subjects engaged in
regular physical training, with their average being less than
1 h per week. Informed consent was obtained from all
subjects, and the Hospital Ethics Review Committee
approved the study.Measurements
Rest measurements
Subjects underwent pulmonary function testing in a hospital
located at sea level (mean atmospheric pressure,
751mmHg). During the first test, height and weight was
measured and body mass index (BMI) (weight (kg)/height
(m)2) was calculated for each subject. Spirometry was
performed using an automated metabolic measuring system
(Oxycon pro, Jaeger, Wu¨rzburg, Germany), which was
calibrated before each study with a known concentration
of gas (i.e. 16% O2 and 4% CO2). Thoracic gas volumes were
determined with a body plethysmograph (Masterlab, Jaeger,
Wu¨rzburg, Germany). A mass flow sensor measured mouth
flow, and volume was obtained by numerical integration of
the flow signal. Partial and maximal flow–volume curves
were obtained as follows: after at least four regular breaths,
subjects forced expiration from end-tidal inspiration to
residual volume (RV), which was immediately followed by a
fast inspiration to total lung capacity (TLC) and a second
forced expiration to residual volume (RV). All ventilatory
parameters such as forced expiratory volume in 1 s (FEV1),
forced vital capacity (FVC), maximum voluntary ventilation
(MVV) and single-breath carbon monoxide diffusion capacity
(DLCO) were obtained according to guidelines.19,21–23 Rest-
ing energy expenditure (REE, expressed as an oxygen
consumption per time unit) was measured during the
patient’s fasting state by indirect calorimetry using a
ventilated hood system (Oxycon pro, Jaeger, Wu¨rzburg,
Germany). Measurements were performed while the sub-
jects were lying in a supine position for 30min. At rest and
on room air, arterial blood was drawn by radial artery
puncture. Arterial oxygen pressure (PaO2), carbon dioxide
pressure (PaCO2), oxygen saturation (SaO2) and pH were
measured by a Ciba Corning 855 gas analyzer (Ciba Corning
Diagnostic, Medfield, MA).
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All subjects completed four distinct exercises in this study.
An incremental exercise was performed to assess physiolo-
gical parameters at peak load exercise. A constant-load
exercise (50% V˙O2max.) was used to determine ME, ventila-
tory and metabolic adaptations. Two sessions were both
accomplished by the use of arm and leg cranking. In the first
session, arm maximal exercises and leg maximal exercises
were performed in a random order, and were separated by
at least 1 week. In the second, arm constant load exercise
and leg constant load maximal exercise were performed in a
random order, and were separated by at least 2 days.
Protocols used were identical during arm and leg exercises
for both groups, and were performed on a Monark Ergomedic
818 (Varberg, Sweden) and a Monark compact rehab 871 E
(Varberg, Sweden), respectively.
For arm exercises, the ergometer was lifted up to such a
height that its cranks shaft was level with the shoulder of
the subject, and the arms were alternatively stretched
horizontally while cranking. Furthermore, the trunk was
stabilized using two anatomic belts that fixed the subject’s
back to a stable support. Indeed, subjects could not use
other muscles except those of arms and shoulders for arm
exercises.
During all exercise tests, subjects breathed through a
mouth-piece from which inspired and expired gas concen-
trations were continuously analyzed with a rapid response
paramagnetic O2 and infrared CO2 analyzers, using a
computerized breath-by-breath exercise system (Oxycon
pro; Jaeger, Wu¨rzburg, Germany). Calibration measure-
ments were carried out according to the manufacturer’s
instructions before each study. In all situations, before
testing, ventilation characteristics were analyzed, at rest
for 3min.
Incremental cycle ergometry tests
After 1min of unload cycling, power was increased by 10W
in the first 3min, then increased constantly every second in
order to have a rise of 6W every minute until exhaustion.
Cycling cadence was imposed at 60 revolutions/min1,
which is considered the optimal energetic cadence.24
Maximal workload was defined as the peak work exercise
corresponding to the highest oxygen uptake value. In order
to determine progressive air trapping and further dynamic
lung hyperinflation (DH) during exercise, inspiratory capa-
city (IC), end expiratory lung volume (EELV) and end
inspiratory lung volume (EILV) were measured as proposed
by Hyatt.25 DH was assessed only during the exhausted
incremental exercise, at rest and at peak load exercise.
Severity of dyspnea was rated using the visual analogue
scale (VAS) scoring between 0 (no dyspnea at all) and 10
(most severe sensation of dyspnea that the patient could
imagine). Measurement of blood lactate concentration
([la]b) enzymatic method (YSI 2300 Stat
s, Yellow Springs
Instruments, OH, USA), immediately after exercise.26
Constant-load exercise
All subjects performed, in a random order, 8-min leg
exercise or arm exercise tests at 50% of individually
measured peak work. Mean values recorded during the lasttwo minutes of exercise were used for analyses. Mechanical
efficiency was calculated from O2 consumption and CO2
production24 from the following equation:
ME ¼ ðpower ðWÞ of exercise
 0:01433 ðkcal=min1Þ=ðenergy
 expenditure during exercise
 REEÞ ðkcal=min1Þ  100%.Statistical analysis
Data were expressed as mean7SEM. The data distribution
was analyzed before each test. Differences between
patients and control subjects were compared using unpaired
Student’s t-test. In the event of cohorts of variables not
having a normal distribution, the Mann–Whitney U-test was
employed.
In each group, results of the arm and leg exercise
protocols were also compared. When the data distribution
reflected a normal distribution, we used a t-test for paired
data. If the distribution was not normal, a non-parametric
Wilcoxon test for paired data was employed.
Differences between groups were considered significant
at Po0.05.Results
Subjects
In our study, patients in the COPD group had moderate to
severe airflow obstruction (FEV1 of 3575% predicted normal
values). Mean anthropometric and resting data for the COPD
patients and control group are presented in Table 1. No
significant differences in age, height, weight or BMI were
observed between the two groups.Incremental cycling exercise
All results are presented in Table 2.
At peak exercise, maximal values of power, V˙O2, RER, V˙E,
and HR were significantly lower in patients with COPD,
compared with healthy controls for both conditions. The
lower ventilation in COPD patients, compared with healthy
controls, was related to a significantly smaller tidal volume
and lower breathing frequency. In the COPD group, for both
conditions, the peak ventilation (expressed as a percentage
of predicted maximal voluntary ventilation) was significantly
higher than in the control group.
In the control group, maximal values of power output,
V˙O2 and V˙E were significantly lower during arm than leg
cycling (mean difference for V˙O2 and V˙E, 27.8% and 20%,
respectively; Po0.05). However, blood lactate concentra-
tion and the dyspnea scale were higher during arm exercise
(Po0.05). We have observed an alteration in maximal power
output corresponding, respectively, to 57% for leg and 35%
for arm in COPD group when compared with healthy subjects
(Po0.05).
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At rest and at peak exercise, no DH was observed among the
control subjects. In contrast, for COPD patients at rest and
peak exercise, in both conditions (arm and leg cranking), we
noted a DH (Po0.05). Furthermore, in this group no
difference in DH values was observed between rest and
peak exercise of either arms or legs (Fig. 1).Table 2 Peak arm and leg exercise responses for both groups.
Arm crank
Controls COPD
Max.W, W 94712.65y 547
V˙O2, mlmin
1 15977168y 10547
RER 1.1570.04 1.097
V˙E, lmin1 61.876.2y 28.97
V˙E/MVV, % 60.274.8y 88.67
VT, l 1.6470.13
y 0.927
fb, breathsmin
1 37.872.9y 31.57
Dyspnea scale 6.771.5y 8.17
HR, beatsmin1 15675.7 1177
Lactate, molml1 8.871.4 4.17
Values are means7SE; V˙O2, O2 consumption; V˙CO2, CO2 excretion;
maximal voluntary ventilation; VT, tidal volume; fb, frequency of b
patients vs. control.
Table 1 Characteristics of subjects at rest.
COPD (n ¼ 16) Control (n ¼ 19)
Age (yrs) 6576.1 6375.3
Height (m) 165712 16978.4
Weight (kg) 75713 79710
BMI (kgm2) 23.576.3 27.3675.8
VC (L) 1.9770.64* 3.9971.12
(%predicted) 59717* 10176
FEV1 (L) 0.93270.25* 2.9770.98
(%predicted) 3575* 10274
FEF 25–75 (L) 2.33670.873* 3.6871.09
(%predicted) 1873* 88715
FEV1/FVC (%) 4875.28* 7575
RV (L) 4.8271.25 –
(%predicted) 221769 –
DLCO (mlmin1mmHg1) 11.876.2 –
(%predicted) 62718 –
SaO2 (%) 9571.8 9871
PaO2 (mmHg) 7473.25 –
PaCO2 (mmHg) 4071.35 –
Arterial pH 7.4170.08 –
Values are means7SE. COPD, chronic obstructive pulmonary
disease; n, no. of subjects; BMI, body mass index; FEV1,
forced expiratory volume in 1 s; FVC, forced vital capacity;
RV, residual volume; DLCO, CO diffusion capacity; SaO2,
oxygen saturation; PaO2, arterial oxygen pressure; PaCO2,
arterial carbon dioxide pressure; *Po 0.05.Constant-load exercise
Parameters recorded during constant load exercise are
presented in Table 3.
In the COPD group, for both exercises, mean values of
power, V˙O2, V˙E, and HR were significantly lower than in the
control group. Furthermore, the lower ventilation values in
the COPD group reflected a significantly smaller tidal volume
and a significantly lower breathing frequency. For both
exercises, the ventilation expressed as a percentage of
predicted maximal voluntary ventilation was similar in
patients with COPD (but significantly higher compared to
controls). In the COPD group, there was no significant
difference in power, V˙O2, RER, V˙E, HR, ME and blood lactate
concentration between leg and arm exercise.
In the control group, values of V˙O2, V˙E, and HR were
significantly lower during arm exercise than during leg
exercise.
During arm exercise no significant difference was ob-
served in ME between COPD patients and control group
(respectively, 20.97%72.33% vs. 25.90%73.30%). In con-
trast, during leg exercise, ME was significantly lower in the
COPD group than in the control group (respectively,
20.91%72.92% vs. 27.38%73.03%, Po 0.05) (Fig. 2).
Discussion
The most striking result of the study was the relatively
diminished impairment during arm than leg exercise, giving
rise to an identical aerobic capacity in arm and leg in
moderate to severe COPD patients.
Impaired aerobic capacity in COPD and the reason of this
dysfunction is now well documented.5 Our results are in
agreement with this observation since our patients with
moderate to severe COPD (FEV1o40% predicted) compared
with healthy subjects. During constant-load exercise,
muscle functions are usually assessed by measurement of
ME.17,18 As the ME of locomotion corresponds to the
efficiency of conversion of chemical energy to kinetic
energy by muscle,24 an alteration in muscle function leadsLeg cycle
Controls COPD
8.54* 162721.50 58710.33*
67* 21907271 11097116*
0.03* 1.1470.05 1.0870.03*
3.21* 77.279.53 31.674.06*
1.6* 74.975.8 9572.1*
0.18* 1.9570.23 0.9870.17*
3.4* 39.873.34 32.573.3*
1.2* 7.571.3 8.971.1*
6* 15775.1 12578.8*
0.7* 7.271.2y 4.370.9*
RER, respiratory exchange ratio; V˙E, minute ventilation; MVV,
reathing; HR, heart rate; yPo0.05 arm vs. leg; *Po0.05 COPD
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Figure 1 Dynamic hyperinflation (DH) assessment in COPD patients and healthy subjects. Subdivisions of lung volume, expressed as
percentage of total lung capacity (TLC) at rest and at peak work exercise during both arm and leg exercise in controls and in patients
with COPD. *Po0.05 leg EILV patients vs. control; *Po0.05.
Table 3 Physiological parameters recorded at 50% peak aerobic capacity.
Arm crank Leg cycle
Controls COPD Controls COPD
50% peak work
V˙O2, mlmin
1 898776y 724737* 12577123 778781*
RER 0.9470.01 0.9870.02* 0.9370.02 0.9770.03*
V˙E, lmin1 26.173.8y 21.273.5* 28.273.7 22.572.3*
V˙E/MVV, % 2572.1 67.775.3* 2773.6 71.473.2*
VT, L 1.2170.21 0.82770.16* 1.2970.20 0.85470.19*
fb, breathsmin
1 21.472.8 25.973.5* 21.972.3 27.173.6*
HR, beatsmin1 93711.8y 9274.6 10876.8 9678.4*
Lactate, molml1 3.770.7y 1.870.3* 2.770.5 1.970.4*
Values are means7SE; V˙O2, O2 consumption; V˙CO2, CO2 excretion; RER, respiratory exchange ratio; V˙E, minute ventilation; MVV,
maximal voluntary ventilation; VT, tidal volume; fb, frequency of breathing; HR, heart rate;
yPo0.05 arm vs. leg; *Po0.05 COPD
patients vs. control.
Exercise in COPD patients 551to an impairment in efficiency. In our study, the ME of leg
cycling was lower in patients with COPD than in controls,
indicating that the skeletal muscle function was altered at
least in lower limb muscle in our COPD patients.
In healthy subjects, when comparing arm and leg
capacities during maximal exercise, it is reported that peak
arm power, peak arm V˙O2 and peak arm V˙E are significantly
lower when compared to peak leg values.16 Our results can
be compared with these previous observations. In the
healthy population, this result is explained by a lower
muscle mass in the arms and by the existence of ventilatory
limitation during arm activities. During arm exercise, some
accessory respiratory muscles, contributing to inspiration
with a fixed extra thoracic anchoring point, are used for arm
crank cycling and may thus impair breathing efficiency.27,28Surprisingly, no difference between arm and leg aerobic
capacity was observed in patients with COPD. This suggests a
higher muscular dysfunction in lower limb muscle compared
to upper limb. Furthermore, at an relative equivalent
workload, there was no statistic difference in ME during
arm exercises between COPD and healthy subjects, whereas
the ME of leg cycling was significantly lower in patients with
COPD than in healthy subjects (Po0.05). This observation
confirms that leg muscles are more profoundly affected than
arm muscles in terms of aerobic capacity.
In order to confirm that the differential aerobic capacity
between the upper and lower limbs is indeed secondary to
impaired muscle function, we plan to analyze the ‘‘out-of-
breath’’ feeling induced by each of these two types of
exercise. In healthy subjects, for an identical relative
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Figure 2 Mechanical efficiency (ME) in COPD patients and in
healthy subjects. Bar diagram of leg and arm mechanical
efficiencies in COPD patients (darkened bars) and healthy
subjects (light bars). Mean values7SEM are shown. Significance
of differences was indicated as *Po 0.05 for COPD patients vs.
healthy subjects.
O. Castagna et al.552workload, the ‘‘out-of-breath’’ feeling is augmented further
during arm exercise than during leg exercise.27 Among
patients with COPD, we observed no significant difference
between the dyspnea associated with peak arm and leg
exercises.
It is accepted that exercising patients with COPD become
out-of-breath for two reasons: (i) ventilatory, notably due to
DH, and (ii) metabolic, as a result of increased lactate
production, in which metabolism is predominantly glycoly-
tic. In our study, impaired ventilatory function cannot
account for why the impression of being dyspneic is the
same regardless of whether the exercise involves the arms
or the legs. In practice, in COPD, we observed no significant
difference in ventilatory parameters (V˙E, Fb and especially
DH) during arm as opposed to leg exercise. In the light of
these findings, we do not believe that ventilatory limitations
in COPD can account for the ‘‘relatively greater degree of
dyspnea’’ observed in the course of leg as opposed to arm
exercise.
Previous studies have suggested that, for the same power
output, arm exercise requires higher oxygen uptake, carbon
dioxide output, and ventilation than leg exercise, and that
response kinetics are slower.29 On the other hand, it is
accepted that, in healthy subjects performing arm exer-
cises, the venous blood lactate concentration is significantly
higher than during leg exercise.30 Several reasons are
proposed to explain this situation, yet the most prominent
is that upper limb muscle fiber typology is more glycolytic
than lower limb muscle fibers. In healthy subjects, our
findings are consistent with previous results of the literature
(with a significantly lower blood lactate concentration
during leg exercises when compared with arm exercises,
Po0.05). Conversely, in subjects with COPD, no significant
difference in blood lactate concentration was observed
between arm and leg values, in either peak or constant-load
exercises. Thus, in COPD, the lack of any difference
between ventilatory parameters between arm and leg could
be mainly due to a metabolic difference in the upper and
lower limbs than to an impaired ventilatory function.
The main result of our study is that in moderate to severe
COPD patients, upper and lower limbs have a similar aerobic
capacity with a comparable DH. This observation suggestsless arm muscle dysfunction in COPD. One possibility is that
a part of the upper limb mass muscle is relatively less
deconditioned compared to the lower limb in COPD patients,
accounting for the relatively preserved values of maximal
workload during arm exercise. In this respect, studies of
skeletal muscle function in COPD have demonstrated that
upper limb muscles were less affected than lower limb
muscles.13,14,31 Thus, the reduction in quadriceps strength
averaged 30% when compared with healthy subjects14,32,33
whereas upper limb strength was relatively preserved
compared with the lower limbs.31 Furthermore, Sato et
al.15 noted that muscular fiber typologies in brachial biceps
were similar to those of healthy subjects. One factor that
may explain these observations is the fact that in COPD,
shoulder girdle muscles such as the pectoralis major and
minor, latissimus dorsi, and serratus are regularly active
during quiet breathing, whereas these muscles are generally
not used during breathing in healthy subjects.30 It may be
that muscles used both for breathing and arm exercises are
relatively less deconditioned than leg muscles in COPD
patients. This phenomenon has also been observed in the
diaphragm: in COPD, impaired function in this muscle is
partially compensated by an increase in its workload.12
In summary, this study indicated that, in patients with
moderate to severe COPD, despite a significant alteration in
muscular function, there was relatively little difference
between upper and lower limb aerobic capacity compared
with healthy individuals. COPD patients may have a
tendency to eliminate lower limb activities involving the
muscles of ambulation, leading to an overall deconditioning.
In our point of view, differences between upper and lower
limb muscle capacities need to be evaluated in patients with
severe to moderate COPD, in order to design suitable
training and rehabilitation procedures.
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